SCHEMBL680070

SCHEMBL680070

CN(C)c1cc2[nH]ncc2cc1Oc1ccc(N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 3/20 0.45
MAPT P10636 3/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
ROCK2 O75116 3/20 0.45
ROCK1 Q13464 2/20 0.45
PKM P14618 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
HTT P42858 1/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 1/20 0.45
HIF1A Q16665 1/20 0.45
CHEK1 O14757 1/20 0.41
TLR8 Q9NR97 1/20 0.39
AXL P30530 1/20 0.38
PIM1 P11309 1/20 0.35
GSK3B P49841 1/20 0.35
AURKB Q96GD4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL680953 0.83 ROCK2 (0.44) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL16711378 0.74 CHEK1 (0.63) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL7210882 0.69 MEN1 (0.72) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL2876364 0.67 ROCK1 (0.58) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL8325177 0.67 ROCK1 (0.58) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL8325182 0.67 KDM4E (0.58) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL3485196 0.67 KDM4E (0.58) ALDH1A1KDM4EMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL5408020 0.66 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL27227850 0.64 CHEK1 (0.63) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL177260 0.64 MAPT (1.00) ALDH1A1KDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2310382-B1 AMIDOPHENOXYINDAZOLES USEFUL AS INHIBITORS OF C-MET LILLY CO ELI (US) 2012-02-22 EP disclosed
US-8030302-B2 Amidophenoxyindazoles useful as inhibitors of c-Met ELI LILLY AND COMPANY (US) 2011-10-04 US disclosed
US-20100022529-A1 AMIDOPHENOXYINDAZOLES USEFUL AS INHIBITORS OF C-MET ELI LILLY AND COMPANY 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022529-A1 AMIDOPHENOXYINDAZOLES USEFUL AS INHIBITORS OF C-MET MET, MYCBP, MYC ALDH1A1 1450/4885KDM4E 1545/4885MAPT 4502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.